{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:01:56Z","timestamp":1761807716418},"publisher-location":"Berlin, Heidelberg","reference-count":18,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642280955"},{"type":"electronic","value":"9783642280962"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/8904_2011_87","type":"book-chapter","created":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T08:29:54Z","timestamp":1323505794000},"page":"21-25","source":"Crossref","is-referenced-by-count":16,"title":["The Use of Elevated Doses of Genistein-Rich Soy Extract in the Gene Expression-Targeted Isoflavone Therapy for Sanfilippo Disease Patients"],"prefix":"10.1007","author":[{"given":"V\u011bra","family":"Malinov\u00e1","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Narajczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,11]]},"reference":[{"key":"87_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10545-009-9029-2","volume":"33","author":"A Arfi","year":"2010","unstructured":"Arfi A, Richard M, Gandolphe C, Scherman D (2010) Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones. J Inherit Metab Dis 33:61\u201367","journal-title":"J Inherit Metab Dis"},{"key":"87_CR2","first-page":"13","volume-title":"Genetic metabolic disorders: management, costs and sociomedical aspects.","author":"M Beck","year":"2007","unstructured":"Beck M (2007) Mucopolysaccharidoses: clinical features and management. In: vom Dahl S, Wendel U, Strohmeyer G (eds) Genetic metabolic disorders: management, costs and sociomedical aspects.. Deutscher Arzte-Verlag, Cologne, pp 13\u201318"},{"issue":"6","key":"87_CR3","doi-asserted-by":"publisher","first-page":"923","DOI":"10.2174\/138920111795542651","volume":"12","author":"J Ruijter de","year":"2011","unstructured":"de Ruijter J, Valstar MJ, Wijburg FA (2011) Mucopolysaccharidosis type III (Sanfilippo syndrome): emerging treatment strategies. Curr Pharm Biotechnol 12(6):923\u2013930","journal-title":"Curr Pharm Biotechnol"},{"key":"87_CR4","doi-asserted-by":"publisher","unstructured":"Delgadillo V, del Mar O\u2019Callaghan M, Artuch R, Montero R, Pineda M (2011) Genistein supplementation in patients affected by Sanfilippo disease. J Inherit Metab Dis 34(5):1039\u20131044, doi:\n                  10.1007\/s10545-011-9342-4","DOI":"10.1007\/s10545-011-9342-4"},{"key":"87_CR5","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1111\/j.1476-5381.2009.00565.x","volume":"159","author":"A Friso","year":"2010","unstructured":"Friso A, Tomanin R, Salvalaio M, Scarpa M (2010) Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II. Br J Pharmacol 159:1082\u20131091","journal-title":"Br J Pharmacol"},{"key":"87_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11011-011-9233-2","volume":"26","author":"A Kloska","year":"2011","unstructured":"Kloska A, Jak\u00f3bkiewicz-Banecka J, Narajczyk M, Banecka-Majkutewicz Z, W\u0119grzyn G (2011) Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses. Metab Brain Dis 26:1\u20138","journal-title":"Metab Brain Dis"},{"key":"87_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00431-007-0462-7","volume":"167","author":"M Malinowska","year":"2008","unstructured":"Malinowska M, Jak\u00f3bkiewicz-Banecka J, Kloska A, Tylki-Szyma\u0144ska A, Czartoryska B, Piotrowska E, Wegrzyn A, Wegrzyn G (2008) Abnormalities in the hair morphology of patients with some but not all types of mucopolysaccharidoses. Eur J Pediatr 167:203\u2013209","journal-title":"Eur J Pediatr"},{"key":"87_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ymgme.2009.06.013","volume":"98","author":"M Malinowska","year":"2009","unstructured":"Malinowska M, Wilkinson FL, Bennett W et al (2009) Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice. Mol Genet Metab 98:235\u2013242","journal-title":"Mol Genet Metab"},{"key":"87_CR9","doi-asserted-by":"publisher","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","volume":"5","author":"M Malinowska","year":"2010","unstructured":"Malinowska M, Wilkinson FL, Langford-Smith KJ et al (2010) Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease. PLoS One 5:e14192","journal-title":"PLoS One"},{"issue":"9","key":"87_CR10","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ajmg.a.34146","volume":"155A","author":"J Marucha","year":"2011","unstructured":"Marucha J, Tylki-Szyma\u0144ska A, Jak\u00f3bkiewicz-Banecka J, Piotrowska E, Kloska A, Czartoryska B, W\u0119grzyn G (2011) Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT). Am J Med Genet A 155A(9):2257\u20132262","journal-title":"Am J Med Genet A"},{"key":"87_CR11","first-page":"3421","volume-title":"The metabolic and molecular bases of inherited disease","author":"EF Neufeld","year":"2001","unstructured":"Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill Co., New York, pp 3421\u20133452"},{"key":"87_CR12","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","volume":"14","author":"E Piotrowska","year":"2006","unstructured":"Piotrowska E, Jakobkiewicz-Banecka J, Baranska S et al (2006) Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses. Eur J Hum Genet 14:846\u2013852","journal-title":"Eur J Hum Genet"},{"key":"87_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.curtheres.2008.04.002","volume":"63","author":"E Piotrowska","year":"2008","unstructured":"Piotrowska E, Jakobkiewicz-Banecka J, Tylki-Szymanska A et al (2008) Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: An open-label, pilot study in 10 pediatric patients. Curr Ther Res Clin Exp 63:166\u2013179","journal-title":"Curr Ther Res Clin Exp"},{"issue":"Suppl 1","key":"87_CR14","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1002\/ptr.2944","volume":"24","author":"E Piotrowska","year":"2010","unstructured":"Piotrowska E, Jak\u00f3bkiewicz-Banecka J, Wegrzyn G (2010) Different amounts of isoflavones in various commercially available soy extracts in the light of gene expression-targeted isoflavone therapy. Phytother Res 24(Suppl 1):S109\u2013S113","journal-title":"Phytother Res"},{"key":"87_CR15","doi-asserted-by":"publisher","first-page":"CR196","DOI":"10.12659\/MSM.881715","volume":"17","author":"E Piotrowska","year":"2011","unstructured":"Piotrowska E, Jakobkiewicz-Banecka J, Maryniak A, Tylki-Szymanska A, Puk E, Liberek A, Wegrzyn A, Czartoryska B, Slominska-Wojewodzka M, Wegrzyn G (2011) Two-year follow-up of Sanfilippo Disease patients treated with a genistein-rich isoflavone extract: Assessment of effects on cognitive functions and general status of patients. Med Sci Monit 17:CR196\u2013CR202","journal-title":"Med Sci Monit"},{"key":"87_CR16","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","volume":"31","author":"MJ Valstar","year":"2008","unstructured":"Valstar MJ, Ruijter GJ, van Diggelen OP, Poorthuis BJ, Wijburg FA (2008) Sanfilippo syndrome: a mini-review. J Inherit Metab Dis 31:240\u2013252","journal-title":"J Inherit Metab Dis"},{"key":"87_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.mehy.2010.07.044","volume":"75","author":"G Wegrzyn","year":"2010","unstructured":"Wegrzyn G, Jak\u00f3bkiewicz-Banecka J, Narajczyk M, Wi\u015bniewski A, Piotrowska E, Gabig-Cimi\u0144ska M, Kloska A, S\u0142omi\u0144ska-Wojew\u00f3dzka M, Korzon-Burakowska A, W\u0119grzyn A (2010a) Why are behaviors of children suffering from various neuronopathic types of mucopolysaccharidoses different. Med Hypoth 75:605\u2013609","journal-title":"Med Hypoth"},{"key":"87_CR18","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1042\/BST0380695","volume":"38","author":"G Wegrzyn","year":"2010","unstructured":"Wegrzyn G, Jak\u00f3bkiewicz-Banecka J, Gabig-Cimi\u0144ska M, Piotrowska E, Narajczyk M, Kloska A, Malinowska M, Dziedzic D, Go\u0142ebiewska I, Moskot M, Wegrzyn A (2010b) Genistein: a natural isoflavone with a potential for treatment of genetic diseases. Biochem Soc Trans 38:695\u2013701","journal-title":"Biochem Soc Trans"}],"container-title":["JIMD Reports","JIMD Reports - Case and Research Reports, 2012\/2"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/8904_2011_87","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T10:58:00Z","timestamp":1557485880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/8904_2011_87"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783642280955","9783642280962"],"references-count":18,"URL":"https:\/\/doi.org\/10.1007\/8904_2011_87","relation":{},"ISSN":["2192-8304","2192-8312"],"issn-type":[{"type":"print","value":"2192-8304"},{"type":"electronic","value":"2192-8312"}],"subject":[],"published":{"date-parts":[[2011]]}}}